2017 Brings Equilibrium for Medical Costs  

Medical Costs in 2017 – Equilibrium

Frank Magliochetti Report

PwC calls 2017 the “year of equilibrium for medical costs” in its recent publication, Medical Cost Trend: Behind the Numbers 2017. Authors of the PwC report expect growth rate for 2017 to remain unchanged at apricewaterhousecoopers_frankmagliochettireport 6.5 percent.

Two main components of healthcare costs:

  • Unit price of services
  • Utilization, which is the volume and intensity of use of those services

Identifying trends in both unit price and utilization elucidates changes in overall spending. In other words, trends in unit prices and utilization provide a clear picture of whether costs are rising or falling, or if consumers are using more or fewer specific services and products.

Price, rather than utilization, had historically been the primary force behind medical cost trends. In the early 2000s, utilization grew to become on par with price as a major contributor to healthcare trend growth. Retail clinics and urgent care centers have made it more convenient for consumers to receive healthcare, and this convenience led to higher utilization. Greater utilization often results in reduced spending later down the road, especially if consumers use these clinics for preventive screening and for treatment of minor conditions before they become serious problems, but these savings may not reduce the short-term costs of higher utilization.

Recently, however, the price trend grew while the utilization trend declined. This decline in utilization shifts the focus back on the price trend, and does it in a frankmagliochettireport-health_costs-trends-2017way that may affect utilization.

Trends to watch in 2017

PwC predicts mainstream attention and regulatory recognition will cause behavioral health, once largely ignored as a necessary health treatment, to become a crucial part of employer health benefits. The organization also expects slower cost growth among specialty drugs for the first time in several years.

PwC expects employers to consider new benefit strategies, especially those that focus on leveraging high-performing networks with lower costs and higher quality.

At 30 percent from hospital inpatient and 19 percent from hospital outpatient, about half of employer health costs currently come from hospital spending, but costs for prescription drug care will probably see modest cost increases in 2017. Political pressure will likely suppress some of the largest drug cost increases. Furthermore, PwC predicts pharmacy benefit managers will adopt new and more aggressive strategies, which will likely contribute to deflation in the medical cost trend.

Business:  What do the Trends Represent

Always looking for new ways to reduce costs, employers will likely focus less on cost sharing and more on sharing new provider networks. They may realign cost sharing for ambulatory services, for example, evaluate current arrangements made by pharmacy benefit managers, or explore high-performance networkmedicalcoststrends_frankmagliochettireport arrangements.

Faced with competition from new sites of care, healthcare providers who want to grow their market share may consider consolidations or affiliations with other health systems. They may create new partnerships with insurers, provide a more convenient healthcare experience to consumers, or collaborate with pharmacy benefits managers.

Insurers may find it challenging to keep premiums low and control costs in 2017. Transforming business models and encouraging patients to visit lower-cost, high quality providers may help.

In all PwC predicts medical costs will continue to rise in 2017 at the same rate as they did in 2016. The authors of the study predict larger increases in the future.

Source

http://www.pwc.com/us/en/health-industries/health-research-institute/behind-the-numbers.html

Frank Magliochetti is Managing Partner for Parcae Capital.

  • North Andover, Massachusetts

This column of posts is directed at the Healthcare Industry.  Frank plans to release a new site dedicated to the industry.  He currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

frankmagliochetti_ParcaeCapital

Healthcare: Smartphone Apps Connecting Patients with Dr’s

Handheld Medicine: Doctors Connecting with Patients using Smartphones

Frank Magliochetti Report

Some fantastic news and what is an absolute healthcare trend; technology is making it easier for communication between DR’s and patients!

Doctors are connecting with patients in an entirely new way – through smartphones.Mobile payments, apps, and digital advertising changed the way retailers work by providing new opportunities to attract new customers, build loyalty and improve sales. Now these same technologies that altered retail are revolutionizing the world of medicine. The use of smartphones and apps helps drive down costs, increases access to information, and fulfills the public’s desire for “anytime, anywhere” diagnosis, treatment and monitoring.

frankmagliochetti_doctormobilevideocallUntil now, the healthcare industry has underutilized smartphones, apps and even connected medical accessories. This is changing, as connectivity allows consumers to take control of their own care. The adoption of mobile health apps has doubled in only two years. The percentage of consumers with at least one medical, health or fitness app increased from 16 percent in 2013 to 32 percent in 2015, according to PWC.

Primary care practitioners and chronic disease managers are leading the way towards a new generation of telemedicine, and patients are eager to follow. Doctors in India set up patients with smart home monitoring kits that connect wireless to the company’s online platform. From there, patients can connect with a wide range of specialists, including dermatologists, cardiologists and fertility doctors who can conduct virtual examinations and prescribe medicine from remote locations.

Clinicians in the United States can now use their smartphones as digital otoscopes. A growing number of clinicians now send patients with chronic conditions home with connected pacemakers, glucose trackers, ECG monitors and other types of remote monitoring devices. Patients can turn their phones into precision digital scales for weighing out food or connect their bathroom scales to mobile app on their phones to track their weight. Symptom checkers, activity trackers, and on-demand e-visits are now available directly to consumers.

The Future of Smartphone Medicine

Moving towards mobile care will cause a dramatic shift in the needs of the healthcare community. Organizations will need assistance managing utilization, connecting healthcare providers working in remote locations, and overseeing the massive amount of data transferred and stored. There will be an increasing need to evaluate the security, privacy and risk associated with using these new tools.frankmagliochetti-report

Connected tools will create fresh links between healthcare and industries with which it rarely interacts, such as retail, hospitality and financial services. Connectivity will also generate more opportunities for healthcare providers and patients to plug in.

Healthcare providers can look forward to engaging in virtual medicine as more facilities build that technology into their long-term strategic plans. Virtual medicine allows health systems to move away from centralized brick-and-mortar locations towards decentralized partnerships and joint ventures to create “bedless” hospitals. Even with the limited smartphone medicine in use today, a growing share of clinicians can already deliver care remotely.

Patients are Eager to Participate

About 68 percent of adults in the United States have smartphones, according to Pew Research Center, which is up from just 35 percent in 2011. Tablet ownership is up to 45 percent.

aha_frankmagliochettiConsumer interest in telemedicine is growing as quickly as interest in smartphones. According to survey results provided by the American Hospital Association, 74 percent of U.S. consumers would be willing to use telehealth services and 30 percent already use computers or mobile devices to check for medical information. Seventy percent are comfortable communicating with their doctors via email, text or video rather than seeing them in person. More than three out of four patients believe that access to care is more important than human interaction with their healthcare providers.

Advanced hardware technology, the introduction of new apps and wireless links facilitates the move towards handheld medicine.

Sources:

http://www.pwc.com/us/en/health-industries/top-health-industry-issues/care-in-palm-of-hand.html

https://www.doctorkepaas.com/

http://www.medicalpracticeinsider.com/news/oto-converting-iphone-digital-otoscope

https://play.google.com/store/apps/details?id=rascsoft.precisionbalance&hl=en

http://weightgurus.com/http://www.pewinternet.org/2015/10/29/technology-device-ownership-2015/

http://www.aha.org/research/reports/tw/15jan-tw-telehealth.pdf

Frank Magliochetti is Managing Partner for Parcae Capital.

  • North Andover, Massachusetts

This column of posts is directed at the Healthcare Industry – Frank is releasing a comprehensive site which will cover the Healthcare – Bio and Pharna industries- titled the Frank Magliochetti report.  Frank currently assists companies who are building, restructuring, transforming and resurrecting there business’s. An example of his client base are, Xenetic Biosciences , IPC Medical Corp, Just Fellowship Corp, Environmental Services Inc., Parsons Post House LLC, ClickStream Corporation as well as having a business talk radio show; The Business Architect on the URBN network.

frankmagliochetti_ParcaeCapital

Cellaviv

A Health and Wellness Project

cellaviv-logo

Frank Magliochetti of Parcae Capital is currently working with Cellaviv an exciting and unique health & wellness company focused on marketing nutraceuticals containing the science of stem cell nutrition.

The company’s  leadership is experienced and has a long term plan for the businesses continued growth and success.

Here we have sourced and aggregated content from the official website.  Please visit the link provided for more detailed information.
https://www.cellaviv.com/index.asp

About Cellaviv

In 2000, Dr. John Capello was stricken with Parkinson Disease symptoms and was forced to retire from the active practice of medicine. This facilitated a search that led him in 2005 to uncover scientific data regarding the ability of certain botanicals to increase adult stem cells in the body’s circulation. Many hours of research were invested by Dr. Cappello to validate the reality of this phenomenon as it related to adult stem cells and the body’s own way to renew itself. Fortunately, Dr. Cappello discovered a way to improve upon what was then available and made it part of his personal daily regimen. Within several months, not only did the Parkinson Disease symptoms begin to disappear but he also experienced improved joint functions. Through his personal experience, Dr. Capello developed a line of patented and patent pending nutraceuticals that contain the science of stem cell nutrition. The products were made available through a direct sales channel that established a large number of loyal customers who were sold on the health benefits.

Cellaviv Opportunity from Emergent Health on Vimeo.

Cellaviv Opportunity

Celebrating Life by providing individuals with the opportunity for enhanced Health, Wellness and Wealth.

If you are looking and are open minded to improved health, wellness and wealth, Cellaviv is delivering the following:

•    Timing – Be one of the first few hundred brand partners in your state.
•    Stock Options – As a publicly traded company (EMGE), Cellaviv leaders can be shareholders and owners.
•    Compensation – Weekly and Monthly bonus incentives fueling an ambitious and lucrative compensation plan.
•    Systems – Mobile and automated systems with unique Wellness Card giveaway program to build your business.
•    Leadership – Executive leaders and advisers with proven track records and a long term plan for the company.
•    International Expansion – Heading south of the border in 2015 and 2016.

EHC

 The Science – Cellaviv

In 2012, the Nobel Committee announced the selection of stem cell researchers John Gurdon of Great Britain and Shinya Yamanaka of Japan for the 2012 Prize in physiology and medicine. In experiments spanning over a 50-year period, Gurdon and Yamanaka “have revolutionized our understanding of how stem cells and organisms develop,” the Committee said in its announcement.
Traditional nutritional supplementation focuses on feeding good ingredients to cells that are dying. Cellaviv was founded with patented and patent pending Stem Cell Nutrition formulations which focus on supporting the release of stem cells so they can do what they are best at – giving you what you need when you need it.

 In fact, stem cell nutrition has been proven to increase the level of adult stem cells in the body by 25 to 30%. 2013 was actually hailed “The Year of the Stem Cell”.Building off this foundation, Cellaviv is leading a campaign to address growing health concerns by promoting health, wellness and wealth to individuals worldwide and take advantage of the following statistics:

•    87% of U.S. consumers take some form of dietary supplements.
•    80% of adults consume some type of energy beverage each day.
•    67% of Americans are concerned about losing weight.
•    38% have a sleep or wakefulness disorder.
•    Heart disease (which includes Heart Disease, Stroke and other Cardiovascular Diseases) is the No. 1 cause of death in the United States, killing nearly 800,000 people per year.
•    The broader Global Health and Wellness market is expected to be a trillion dollar industry by the end of 2017.
•    Health trends are continuing to move from reactive to proactive and from treatment to prevention

Frank Magliochetti is managing partner of Parcae Capital Corporation.

Med-Final

 

About Frank Magliochetti

frankmagliochetti_ParcaeCapital

North Andover businessman Frank Magliochetti  is  managing partner at Parcae Capital Corporation.

Parcae Capital provides financial restructuring and interim management to emerging businesses.

ParceaCapitalCorporation_Frank-Magliochetti

Parcae Capital offers personalized investment banking services for emerging growth companies. They specialize in finding companies which have leading edge technology, services or intellectual property in the healthcare, media and alternative energy space. Parcae Capital assist both public and private companies in preparing to raise private and public capital for all phases of growth. Parcae Capital also offers comprehensive assistance in mergers, acquisitions and related services. Their work out group specializes in business restructuring and recapitalization.

Frank is also the Chairman at Rehab Medical Holdings Incorporated an orthopedic medical device holding company.

Frank also participates on the Parcae Capital sponsored Day Trader Picks website.

In the past, Frank HAS held positions as Chairman and CEO at Chartwell Diversified Services,  SVP at Sandoz,  VP of North American Operations for Haemonics and CEO for Worldwide Cardiovascular Division for Kontron Medical.

To contact Frank please CLICK HERE

 

Frank Magliochetti – On the Move

-Frank Magliochetti  Radio Show Host?

The summer and fall months have been quite busy for the managing partner at Parcae Capital  Frank Magliochetti – Frank has been on the move!

Frank was uncanny with the pick hits and content on Absolute Day Traders .  Take for example the hot pick hit company OPKO Health.  The ongoing posts featuring Opko Healthone of Absolute Day Trader Picks  pick hit companies were dead on as the company started hitting it big late August and fast became trending on numerous sites as a must have addition to your watch list.    Mr Magliochetti was way out in front of this pick hit compan.  For months leading up to OPKO making headlines Frank was posting about the important activity going on there.    – Keep an eye on the pick hits from Frank  on Absolute Day Traders!

Frank found time to co-host the popular internet business radio show MYOB on the UR Business Network with show creator and UR Business Network  founder Rick Brutti.

Frank welcomed two innovative pioneers as guests to speak on their respective fields, both  guests made for some interesting and lively conversation.

Meet Peter Weinstein founder and SEO of  One3 IP.

LISTEN TO THE INTERVIEW – CLICK HERE!

Here is some information Boston Financial Guide curated from the One3 IP  website to share with you while listening to the interview. We urge you to visit their website for more details about  One3 IP by clicking HERE.

ONE3IP_FRANKBAGLIOCHETTI

About Us

One3 IP Management was founded based on several key principles that can be summed up as, One3 IP guarantees that it will focus on our clients’ needs and will continually strive to provide our clients the best service, the best results at a price that our clients can afford.  In a nutshell, our clients’ needs will always come first.  Contact One3 IP and let us show you how it is done.

Core Values

One3 IP Management views your intellectual property differently than general practice and patent law firms. To One3 IP, its clients are partners, whose success is One3 IP’s goal. One3 IP is driven to bring the highest quality work to its clients by focusing on the client’s needs.

Our Clients

No matter what industry or technology your company practices, One3 IP can handle your intellectual property and licensing needs. One3 IP represents clients in many different industries around the world, including in biotechnology, pharmaceuticals, medical information, medical device, hardware and software, personal products, sportswear and other technology fields.

Who We Are

One3 IP is an intellectual property management company that works as a partner with its clients to help them protect their intellectual property in a manner that obtains the broadest patent protection available, while also helping its clients establish, implement and follow through on the procedures necessary to protect non-patented trade secrets in a legally enforceable manner. By doing this, One3 IP is able to maximize the monetary and protective value of its clients intellectual property. One3 IP also handles its clients licensing needs, from simple Confidentiality Agreements to complex Research and Development Collaboration Agreements. Let One3 IP be your company’s partner. One3 IP does all this in a cost effective manner that fits within its client’s budget.

Meet  Xenetic CEO Scott Maguire and listen to what Xenetic is doing and how it may  impact the Boston Financial landscape.

CLICK HERE – to listen to the interview!

xenetic_bioscience-Logo

Xenetic is a leading UK-based bio pharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies and vaccines.

Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.

We are also actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen,Oncohist and ImuXen platform technologies.

Here are some of the facts curated by Boston Financial Guide from  the Xenetic website

Product Pipeline

Protein drugs and vaccines

Xenetic’s biopharmaceutical pipeline contains a range of product candidates which are currently under development either in-house or with biotechnology and pharmaceutical partners.  The products in Xenetic’s pipeline have a multi-billion dollar market potential.

Frank Magliochetti is managing partner at Parcae Capital.

North Andover MA based Parcae Capital offers personalized investment banking services for emerging growth companies. They specialize in finding companies which have leading edge technology, services or intellectual property in the healthcare, media and alternative energy space. Parcae Capital assists both public and private companies in preparing to raise private and public capital for all phases of growth. Parcae Capital also offers comprehensive assistance in mergers, acquisitions and related services. Their work out group specializes in business restructuring and recapitalization.